Département de Génie Chimique, École Polytechnique de Montréal, C.P. 6079, Succ. Centre-ville, Montréal, Québec, Canada H3C 3A7.
Human Health Therapeutics Portfolio, National Research Council, 6100 Royalmount Avenue, Montréal (Québec), H4P 2R2, Canada.
J Biotechnol. 2014 Jan;169:63-70. doi: 10.1016/j.jbiotec.2013.11.002. Epub 2013 Nov 15.
The expression of recombinant yeast pyruvate carboxylase (PYC) in animal cell lines was shown in previous studies to reduce significantly the formation of waste metabolites, although it has translated into mixed results in terms of improved cellular growth and productivity. In this work, we demonstrate that the unique phenotype of PYC expressing cells can be exploited through the application of a dynamic fed-batch strategy and lead to significant process enhancements. Metabolically engineered HEK293 cells stably producing human recombinant IFNα2b and expressing the PYC enzyme were cultured in batch and fed-batch modes. Compared to parental cells, the maximum cell density in batch was increased 1.5-fold and the culture duration was extended by 2.5 days, but the product yield was only marginally increased. Further improvements were achieved by developing and implementing a dynamic fed-batch strategy using a concentrated feed solution. The feeding was based on an automatic control-loop to maintain a constant glucose concentration. This strategy led to a further 2-fold increase in maximum cell density (up to 10.7×10(6)cells/ml) and a final product titer of 160mg/l, representing nearly a 3-fold yield increase compared to the batch process with the parental cell clone.
先前的研究表明,在动物细胞系中表达重组酵母丙酮酸羧化酶(PYC)可以显著减少废物代谢物的形成,尽管在提高细胞生长和生产力方面的效果参差不齐。在这项工作中,我们证明了通过应用动态分批策略可以利用表达 PYC 的细胞的独特表型,并带来显著的工艺增强。稳定生产人重组 IFNα2b 并表达 PYC 酶的代谢工程化 HEK293 细胞在分批和补料分批模式下进行培养。与亲本细胞相比,分批培养的最大细胞密度提高了 1.5 倍,培养时间延长了 2.5 天,但产物产量仅略有增加。通过开发和实施使用浓缩补料溶液的动态补料分批策略进一步得到了改进。补料基于自动控制回路以维持恒定的葡萄糖浓度。该策略使最大细胞密度进一步提高了 2 倍(最高达到 10.7×10(6)cells/ml),最终产物滴度达到 160mg/l,与亲本细胞克隆的分批过程相比,产量增加了近 3 倍。